Patients at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare were the first in the nation to participate in a clinical trial to determine the safety, tolerability and effectiveness for usage of a new drug combination consisting of a standard drug called gemcitabine and a drug called nab-paclitaxel for patients with advanced pancreatic cancer.

Results lead to Scottsdale oncologists heading a large Phase III study being conducted worldwide SCOTTSDALE, Ariz., Oct.

DALLAS and NEW YORK, May 10, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.

NEW YORK, Dec.

Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.